Certainly interesting timing, just prior to ASCO. I added some today, and will add more tomorrow. I look at market cap of company and find it difficult to understand why it's so low having had great trial results, SPA and having moved into phase 3. Share price seems super cheap to me.
Apparently 17.7 milly doesn't go as far as it used to. LOL On track for another small r/s about 2 years out at projected registration of drug if all goes well? Buy the bottom after it is all said and done. imo
News 
Market Data 
Discover 
